Here we critically review studies that used electroencephalography (EEG) or event-related potential (ERP) indices as a biomarker of Alzheimer's disease. In the first part we overview studies that relied on visual inspection of EEG traces and spectral characteristics of EEG. Second, we survey analysis methods motivated by dynamical systems theory (DST) as well as more recent network connectivity approaches. In the third part we review studies of sleep. Next, we compare the utility of early and late ERP components in dementia research. In the section on mismatch negativity (MMN) studies we summarize their results and limitations and outline the emerging field of computational neurology. In the following we overview the use of EEG in the diff...
peer reviewedEarly biomarkers are needed to identify individuals at high risk of preclinical Alzheim...
Background So far, no cost-efficient, widely-used biomarkers have been established to facilitate the...
International audienceAbstract Early biomarkers are needed to identify individuals at high risk of p...
Here we critically review studies that used electroencephalography (EEG) or event-related potential ...
Alzheimer’s disease (AD) is a neurodegenerative disorder that accounts for nearly 70% of the more th...
Current biomarkers used in research and in clinical practice in Alzheimer's Disease (AD) are the ana...
Cerebrospinal and structural-molecular neuroimaging in-vivo biomarkers are recommended for diagnosti...
Electrophysiology provides a real-time readout of neural functions and network capability in differe...
Alzheimer's disease (AD) is the most common form of neurodegenerative dementia accounting for 50-80%...
Alzheimer's disease (AD) is the most common neurodegenerative disease among the elderly with a progr...
Electrophysiology provides a real-time readout of neural functions and network capability in differe...
Electrophysiology provides a real-time readout of neural functions and network capability in differe...
The main aims of this thesis were to explore whether quantitative EEG (qEEG) variables could be cons...
Cerebrospinal and structural-molecular neuroimaging in-vivo biomarkers are recommended for diagnosti...
peer reviewedEarly biomarkers are needed to identify individuals at high risk of preclinical Alzheim...
Background So far, no cost-efficient, widely-used biomarkers have been established to facilitate the...
International audienceAbstract Early biomarkers are needed to identify individuals at high risk of p...
Here we critically review studies that used electroencephalography (EEG) or event-related potential ...
Alzheimer’s disease (AD) is a neurodegenerative disorder that accounts for nearly 70% of the more th...
Current biomarkers used in research and in clinical practice in Alzheimer's Disease (AD) are the ana...
Cerebrospinal and structural-molecular neuroimaging in-vivo biomarkers are recommended for diagnosti...
Electrophysiology provides a real-time readout of neural functions and network capability in differe...
Alzheimer's disease (AD) is the most common form of neurodegenerative dementia accounting for 50-80%...
Alzheimer's disease (AD) is the most common neurodegenerative disease among the elderly with a progr...
Electrophysiology provides a real-time readout of neural functions and network capability in differe...
Electrophysiology provides a real-time readout of neural functions and network capability in differe...
The main aims of this thesis were to explore whether quantitative EEG (qEEG) variables could be cons...
Cerebrospinal and structural-molecular neuroimaging in-vivo biomarkers are recommended for diagnosti...
peer reviewedEarly biomarkers are needed to identify individuals at high risk of preclinical Alzheim...
Background So far, no cost-efficient, widely-used biomarkers have been established to facilitate the...
International audienceAbstract Early biomarkers are needed to identify individuals at high risk of p...